Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOLIFENACIN vs SOLRIAMFETOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOLIFENACIN vs SOLRIAMFETOL: Safety Overview

Metric SOLIFENACIN SOLRIAMFETOL
Total FAERS Reports 8,324 2,135
Deaths Reported 206 9
Death Rate 2.5% 0.4%
Hospitalizations 1,201 75
Average Patient Age 68.9 yrs 43.2 yrs
% Female Patients 68.1% 71.4%
FDA Approval Date Apr 13, 2020 Jun 17, 2019
Manufacturer Ajanta Pharma USA Inc. Axsome Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription